Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
Public ClinicalTrials.gov record NCT02288273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes
Study identification
- NCT ID
- NCT02288273
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 239 participants
Conditions and interventions
Conditions
Interventions
- Bydureon Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2014
- Primary completion
- Jul 31, 2015
- Completion
- Jul 31, 2015
- Last update posted
- Jan 26, 2017
2014 – 2015
United States locations
- U.S. sites
- 29
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Anaheim | California | — | — |
| Research Site | Chino | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | North Hollywood | California | — | — |
| Research Site | Santa Ana | California | — | — |
| Research Site | Spring Valley | California | — | — |
| Research Site | Tustin | California | — | — |
| Research Site | Walnut Creek | California | — | — |
| Research Site | Hollywood | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Port Orange | Florida | — | — |
| Research Site | Marietta | Georgia | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Edina | Minnesota | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Butte | Montana | — | — |
| Research Site | Las Vegas | Nevada | — | — |
| Research Site | Franklin | Ohio | — | — |
| Research Site | Marion | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Mt. Pleasant | South Carolina | — | — |
| Research Site | Rapid City | South Dakota | — | — |
| Research Site | Corpus Christi | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Katy | Texas | — | — |
| Research Site | Salt Lake City | Utah | — | — |
| Research Site | Burke | Virginia | — | — |
| Research Site | Manassas | Virginia | — | — |
| Research Site | Olympia | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02288273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 26, 2017 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02288273 live on ClinicalTrials.gov.